Merck & Co Inc
NYSE: MRK
$100.09
+$0.44 (+0.4%)
Closing Price on January 15, 2025
MRK Articles
It’s another rough trading day in the stock market. It is bad enough that the DJIA is down over 3% to decade lows and under 7,000… But even almost all of the defensive stocks are down today. ...
Published:
Last Updated:
Biogen Idec Inc. (NASDAQ: BIIB) is set to report earnings on Friday morning. What many investors probably want to know is if these results — or more importantly its guidance — show that this...
Published:
Last Updated:
It looks like we have our most likely candidates for the "Dogs of the Dow" for 2009. This is often misunderstood as an investment vehicle. These are the 10 highest dividend-yielding stocks out of...
Published:
The Dogs of the Dow are often misunderstood as an investment vehicle. These are technically the 10 highest dividend-yielding stocks out of the 30 DJIA components. The formal list of the ten Dogs...
Published:
Last Updated:
People who get to the end of 2008 and are still at work can be thankful. The unemployment rate will probably be over 7%. That does not count the people no longer looking for work. Add them in and the...
Published:
Last Updated:
According to Reuters, the House will vote on the auto bailout as early as this week. Reuters writes that Rio Tinto (RTP) will cut 14,000 jobs. Reuters reports that AIG (AIG) owes other firms $10...
Published:
Last Updated:
Merck & Co., Inc. (NYSE: MRK) today outlined its drug pipeline and has reaffirmed its guidance given last week. Merck plans to emerge next year and into the next decade leaner and more...
Published:
It is easy to get pumped up about overseas rate cuts, but there is cautionary data from at least three DJIA components. Wal-Mart is the economic trade-down so that win in retail sales is a little...
Published:
So much fore feeling better in a bad economy. Merck (MRK) offered lackluster guidance for next year and the stock is off before the open. According to Reuters, "Merck said it expected earnings,...
Published:
Last Updated:
According to Reuters, former Citigroup (C) CEO Sandy Weill may start a fund to invest in distressed financial companies. Reuters writes that Amazon (AMZN) turned in a weak forecast hurting its stock....
Published:
Last Updated:
Dynavax Technologies Corp. (NASDAQ: DVAX) is the latest biotech implosion as shares are down some 75% today. The company gave an update on an FDA clinical hold on its investigational vaccine...
Published:
Last Updated:
A lot of people believe that Merck (MRK) knew a lot more about the dangers of its arthritis drug Vioxx than the company ever let on. Heart problems were apparently a by-product of using the...
Published:
Last Updated:
According to Reuters, the Treasury will make $250 billion directly into banks. Ciitgroup (C) and JPMorgan (JPM) would get $26 billion each. Merrill Lynch (MER) and Bank of America (BAC) would each...
Published:
Last Updated:
Carl Icahn appears to have won a blue ribbon for ImClone Systems (NASDAQ: IMCL) shareholders. The biotech stock is trading up on a very weak trading day after what many had deemed as a fishy merger...
Published:
Last Updated:
According to Reuters, the House will vote on the bailout bill today. Reuters reports that JP Morgan (JPM) will not keep the CEO of WaMu. Reuters reports that John Thain of Merrill Lynch (MER) will...
Published:
Last Updated:
Our expert who first called NVIDIA in 2009 is predicting 2025 will see a historic AI breakthrough.
You can follow him investing $500,000 of his own money on our top AI stocks for free.